Jaguar Health, Inc. (JAGX)
0.319
-0.05
(-12.91%)
USD |
NASDAQ |
Sep 10, 16:00
0.3237
0.00 (0.00%)
After-Hours: 20:00
Jaguar Health Shareholders Equity (Quarterly) : 6.615M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.615M |
| March 31, 2026 | -14.18M |
| December 31, 2025 | -17.29M |
| September 30, 2025 | 5.627M |
| June 30, 2025 | 7.988M |
| March 31, 2025 | 4.267M |
| December 31, 2024 | 9.77M |
| September 30, 2024 | 16.10M |
| June 30, 2024 | 19.39M |
| March 31, 2024 | 14.48M |
| December 31, 2023 | 4.961M |
| September 30, 2023 | 1.36M |
| June 30, 2023 | 5.637M |
| March 31, 2023 | 7.35M |
| December 31, 2022 | -0.657M |
| September 30, 2022 | 3.647M |
| June 30, 2022 | 2.716M |
| March 31, 2022 | 8.045M |
| December 31, 2021 | 11.61M |
| September 30, 2021 | 21.55M |
| June 30, 2021 | 31.78M |
| March 31, 2021 | 31.89M |
| December 31, 2020 | 17.20M |
| September 30, 2020 | 7.806M |
| June 30, 2020 | 12.42M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.61M |
| December 31, 2019 | 20.57M |
| September 30, 2019 | 20.38M |
| June 30, 2019 | 7.356M |
| March 31, 2019 | 15.80M |
| December 31, 2018 | 14.38M |
| September 30, 2018 | 19.32M |
| June 30, 2018 | 23.02M |
| March 31, 2018 | 30.01M |
| December 31, 2017 | 17.26M |
| September 30, 2017 | 31.81M |
| June 30, 2017 | -6.267M |
| March 31, 2017 | -6.191M |
| December 31, 2016 | -2.454M |
| September 30, 2016 | -0.273M |
| June 30, 2016 | 1.565M |
| March 31, 2016 | 4.648M |
| December 31, 2015 | 4.399M |
| September 30, 2015 | 8.366M |
| June 30, 2015 | 11.11M |
| March 31, 2015 | -4.363M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 3.042M |
| March 31, 2014 | 3.005M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Reviva Pharmaceuticals Holdings, Inc. | 15.21M |
| Jupiter Neurosciences, Inc. | -0.366M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.19M |
| Total Liabilities (Quarterly) | 29.27M |
| Debt to Equity Ratio | 2.767 |
| Current Ratio | 0.6908 |
| Net Debt Paydown Yield | 27.49% |